Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 7 - Number 2


Oncolytic Virus Therapy - Foreword

, 7(2): 123 - 125

H. Kasuya, S. Takeda, S. Shimoyama, T. Shikano, N. Nomura, N. Kanazumi, S. Nomoto, H. Sugimoto and A. Nakao


DOI: 10.2174/156800907780058826






Phase 1 Clinical Experience Using Intravenous Administration of PV701, an Oncolytic Newcastle Disease Virus

, 7(2): 157 - 167

Robert M. Lorence, M. Scot Roberts, James D. O'Neil, William S. Groene, Jeffrey A. Miller, Stephen N Mueller and Michael K. Bamat


DOI: 10.2174/156800907780058853


Clinical Experiment of Mutant Herpes Simplex Virus HF10 Therapy for Cancer

, 7(2): 169 - 174

A. Nakao, S. Takeda, S. Shimoyama, H. Kasuya, H. Kimata, O. Teshigahara, M. Sawaki, T. Kikumori, Y. Kodera, T. Nagasaka, F. Goshima, Y. Nishiyama and T. Imai


DOI: 10.2174/156800907780058808







Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

Oct-2021-ban

Related Journals

Related eBooks

eBooks Catalog